Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates

Celine Boschi (1, 2) , Marion Le Bideau (2) , Julien Andreani (1, 2) , Sarah Aherfi (1, 2) , Priscilla Jardot (2) , Jeremy Delerce (1, 2) , Mathieu Gendrot (2, 3, 4) , Bruno Pradines (2, 3, 4) , Philippe Colson (1, 2) , Anthony Levasseur (1, 2) , Bernard La Scola (1, 2)

1 MEPHI - Microbes évolution phylogénie et infections
2 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
3 VITROME - Vecteurs - Infections tropicales et méditerranéennes
4 IRBA - Institut de Recherche Biomédicale des Armées [Antenne Marseille]

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Celine Boschi, Marion Le Bideau, Julien Andreani, Sarah Aherfi, Priscilla Jardot, et al.. Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates. Frontiers in Bioscience-Landmark, 2021, 26 (12), pp.1493-1502. ⟨10.52586/5043⟩. ⟨hal-03663682⟩